Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Advisor, aforementioned, Alexion, alia, ancillary, bifurcated, burden, Choi, circumvention, Cocrystal, collateral, conversion, correct, Counterclaim, customer, deficiency, degradation, denying, discrepancy, dominant, drafting, dual, earliest, EASL, Enanta, encapsidation, enjoin, ETV, exacerbate, Fargo, frame, front, GalNAc, Gastroenterology, glycolate, greatest, HBx, immaterial, impracticable, inflow, infrastructure, injunction, injunctive, Intellia, inter, Interbank, interdependent, intraday, kind, lender, LIBOR, MAA, manipulation, margin, mathematical, Modulator, outlook, overriding, overstatement, PegIFN, Perelman, pgRNA, poster, predominant, premium, presidential, procedure, purporting, rcDNA, reform, relief, renovate, repaid, repay, repeal, repealed, smaller, software, sophisticated, spreadsheet, steady, Sterilizer, supervision, Supplementary, Supreme, synergistic, titled, Topline, transition, Triple, Trump, uncoating, undelivered, understatement, unexercised, urged, urine, vitro, vivo, Warminster, withholding, wrongly
Removed:
AG, AlCana, Amyloidotic, awaiting, biomedical, body, bringing, choose, closed, conference, convert, dealing, declaration, demanded, determinable, discovered, element, emergency, employ, encapsulated, encouraging, filer, forfeiture, Germany, Hangzhou, Herrington, hiring, hosted, identifying, improving, initiate, irregular, Kowalski, labelling, LLP, manager, moved, moving, nil, North, payload, Polyneuropathy, prescribe, presenting, produced, provisional, reach, reaction, realizable, realize, relationship, safeguarded, San, submitted, Sutcliffe, systemic, translate, underwriter, USA, wide, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 10.62 Ex 10.62 Dod Termination
- 10.63 Exhibit 10.63 Neurovive Termination
- 10.64 Ex 10.64 Dicerna Termination
- 10.65 Ex 10.65 Cytos Termination
- 10.66 Ex 10.66 Bill Symonds Employ Amemd
- 10.67 Ex 10.67 Alexion License Agreement
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1 10K CEO
- 31.2 Exhibit 31.2 10-K CFO
- 32.1 Exhibit 32.1 CEO Sox
- 32.2 Exhibit 32.2 CFO Sox
- Download Excel data file
- View Excel data file
Related press release
ABUS similar filings
Filing view
External links
Exhibit 10.65
August 25, 2016
Didier Cowling
Chief Executive Officer
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
Switzerland
Dear Mr. Cowling,
This letter constitutes written notice of termination by Arbutus Biopharma Inc., and its parent company Arbutus Pharma Corp. (collectively “Arbutus”) of the License Agreement by and between Cytos Biotechnology Ltd and Oncore Biopharma, Inc. (predecessor in interest of Arbutus), dated December 30, 2014 (“Agreement”), pursuant to § 12.3 (Termination of the Agreement for Convenience) of said Agreement.
Yours truly,
/s/ Elizabeth Howard
Elizabeth Howard
Executive Vice President & General Counsel
Cc: VISCHER AG
Aeschenvorstadt 4
4010 Basel
Switzerland
Attn: Dr. Matthias Staehelin